Literature DB >> 23760761

Skin manifestations of primary immune deficiency.

Heather Lehman1.   

Abstract

Cutaneous manifestations are common in primary immune deficiency diseases, affecting between 40 % and 70 % of patients with diagnosed primary immune deficiency. Skin infections characterize many primary immune deficiencies, but there are also frequent noninfectious cutaneous manifestations seen in many of these disorders, including eczematous lesions, erythroderma, cutaneous granulomas, dysplasia of skin, hair, and nails, autoimmune conditions, and frank vasculitis. For the patient with suspected primary immunodeficiency, much can be inferred by evaluating the presenting cutaneous findings, including various infectious susceptibilities, presence of atopy, and evidence of impaired or overactive inflammatory response. The skin manifestations of primary immune deficiency diseases are often early or heralding findings of the underlying immunologic disease. Therefore, awareness of associations between skin findings and immune deficiency may aide in the early detection and treatment of serious or life-threatening immunologic defects. This review summarizes the common skin manifestations of primary immune deficiency diseases and provides the reader with a differential diagnosis of primary immune defects to consider for the most common skin manifestations.

Entities:  

Mesh:

Year:  2014        PMID: 23760761     DOI: 10.1007/s12016-013-8377-8

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   10.817


  68 in total

1.  Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome.

Authors:  S Chavanas; C Bodemer; A Rochat; D Hamel-Teillac; M Ali; A D Irvine; J L Bonafé; J Wilkinson; A Taïeb; Y Barrandon; J I Harper; Y de Prost; A Hovnanian
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

Review 2.  Cutaneous complications of BCG vaccination in infants with immune disorders: two cases and a review of the literature.

Authors:  R J Antaya; E S Gardner; M S Bettencourt; M Daines; Y Denise; S Uthaisangsook; R H Buckley; N S Prose
Journal:  Pediatr Dermatol       Date:  2001 May-Jun       Impact factor: 1.588

Review 3.  Neonatal erythroderma: differential diagnosis and management of the "red baby".

Authors:  P H Hoeger; J I Harper
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

4.  Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis.

Authors:  Nicolas Ramoz; Luis-Alfredo Rueda; Bakar Bouadjar; Luz-Stella Montoya; Gérard Orth; Michel Favre
Journal:  Nat Genet       Date:  2002-11-11       Impact factor: 38.330

5.  A multiinstitutional survey of the Wiskott-Aldrich syndrome.

Authors:  K E Sullivan; C A Mullen; R M Blaese; J A Winkelstein
Journal:  J Pediatr       Date:  1994-12       Impact factor: 4.406

6.  Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency.

Authors:  Agata Drewniak; Roel P Gazendam; Anton T J Tool; Michel van Houdt; Machiel H Jansen; John L van Hamme; Ester M M van Leeuwen; Dirk Roos; Emmanuel Scalais; Carine de Beaufort; Hans Janssen; Timo K van den Berg; Taco W Kuijpers
Journal:  Blood       Date:  2013-01-18       Impact factor: 22.113

Review 7.  Linking albinism and immunity: the secrets of secretory lysosomes.

Authors:  Jane Stinchcombe; Giovanna Bossi; Gillian M Griffiths
Journal:  Science       Date:  2004-07-02       Impact factor: 47.728

8.  Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.

Authors:  B Piqueras; C Lavenu-Bombled; L Galicier; F Bergeron-van der Cruyssen; L Mouthon; S Chevret; P Debré; C Schmitt; E Oksenhendler
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

9.  Cutaneous purulent aspergillosis in a young man with chronic granulomatous disease.

Authors:  S Chatzipanagiotou; K Takou; A Perogamvros
Journal:  Mycoses       Date:  1998-11       Impact factor: 4.377

Review 10.  The genetics and clinical manifestations of telomere biology disorders.

Authors:  Sharon A Savage; Alison A Bertuch
Journal:  Genet Med       Date:  2010-12       Impact factor: 8.822

View more
  10 in total

1.  IgM Plasma Cells Reside in Healthy Skin and Accumulate with Chronic Inflammation.

Authors:  R Paul Wilson; Shannon E McGettigan; Van Duc Dang; Anil Kumar; Michael P Cancro; Neda Nikbakht; William Stohl; Gudrun F Debes
Journal:  J Invest Dermatol       Date:  2019-05-30       Impact factor: 8.551

Review 2.  The influence of skin microorganisms on cutaneous immunity.

Authors:  Yasmine Belkaid; Samira Tamoutounour
Journal:  Nat Rev Immunol       Date:  2016-05-27       Impact factor: 53.106

Review 3.  Skin microbiota-host interactions.

Authors:  Y Erin Chen; Michael A Fischbach; Yasmine Belkaid
Journal:  Nature       Date:  2018-01-24       Impact factor: 49.962

4.  Prevalence of Granulomas in Patients With Primary Immunodeficiency Disorders, United States: Data From National Health Care Claims and the US Immunodeficiency Network Registry.

Authors:  Jessica Leung; Kathleen E Sullivan; Ludmila Perelygina; Joseph P Icenogle; Ramsay L Fuleihan; Tatiana M Lanzieri
Journal:  J Clin Immunol       Date:  2018-07-24       Impact factor: 8.317

Review 5.  Clinical Manifestation of Hyper IgE Syndrome Including Otitis Media.

Authors:  Jing Wu; Li Hong; Tong-Xin Chen
Journal:  Curr Allergy Asthma Rep       Date:  2018-08-15       Impact factor: 4.919

6.  Cutaneous Manifestations of Primary Immunodeficiency Diseases in Tunisian Children.

Authors:  Naouel Guirat Dhouib; Monia Ben Khaled; Monia Ouederni; Imen Ben-Mustapha; Ridha Kouki; Habib Besbes; Mohamed Ridha Barbouche; Fethi Mellouli; Mohamed Bejaoui
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-11-01       Impact factor: 2.576

7.  Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndrome.

Authors:  Rosita Rigoni; Elena Fontana; Kerry Dobbs; Veronica Marrella; Valentina Taverniti; Virginia Maina; Amanda Facoetti; Giovanna D'Amico; Waleed Al-Herz; Mario Ernesto Cruz-Munoz; Catharina Schuetz; Andrew R Gennery; Elizabeth K Garabedian; Silvia Giliani; Deborah Draper; Ghassan Dbaibo; Raif S Geha; Isabelle Meyts; Thomas Tousseyn; Benedicte Neven; Despina Moshous; Alain Fischer; Ansgar Schulz; Andrea Finocchi; Douglas B Kuhns; Danielle L Fink; Michail S Lionakis; Muthulekha Swamydas; Simone Guglielmetti; Julie Alejo; Ian A Myles; Stefania Pittaluga; Luigi D Notarangelo; Anna Villa; Barbara Cassani
Journal:  J Allergy Clin Immunol       Date:  2020-04-18       Impact factor: 10.793

8.  Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity.

Authors:  Ludmila Perelygina; Raeesa Faisthalab; Emily Abernathy; Min-Hsin Chen; LiJuan Hao; Lionel Bercovitch; Diana K Bayer; Lenora M Noroski; Michael T Lam; Maria Pia Cicalese; Waleed Al-Herz; Arti Nanda; Joud Hajjar; Koen Vanden Driessche; Shari Schroven; Julie Leysen; Misha Rosenbach; Philipp Peters; Johannes Raedler; Michael H Albert; Roshini S Abraham; Hemalatha G Rangarjan; David Buchbinder; Lisa Kobrynski; Anne Pham-Huy; Julie Dhossche; Charlotte Cunningham Rundles; Anna K Meyer; Amy Theos; T Prescott Atkinson; Amy Musiek; Mehdi Adeli; Ute Derichs; Christoph Walz; Renate Krüger; Horst von Bernuth; Christoph Klein; Joseph Icenogle; Fabian Hauck; Kathleen E Sullivan
Journal:  Front Immunol       Date:  2021-12-20       Impact factor: 7.561

9.  IL-17-Dependent Dysregulated Cutaneous Immune Homeostasis in the Absence of the Wiskott-Aldrich Syndrome Protein.

Authors:  Katherine E Herman; Takeshi Yoshida; Angela Hughson; Alex Grier; Steven R Gill; Lisa A Beck; Deborah J Fowell
Journal:  Front Immunol       Date:  2022-02-21       Impact factor: 8.786

Review 10.  Applications of Human Skin Microbiota in the Cutaneous Disorders for Ecology-Based Therapy.

Authors:  Hong Zhou; Linlin Shi; Yuanyuan Ren; Xi Tan; Wei Liu; Zhi Liu
Journal:  Front Cell Infect Microbiol       Date:  2020-10-22       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.